A manufacturing subcontractor in Baltimore mixed ingredients from the coronavirus vaccines of Johnson & Johnson and AstraZeneca, setting back U.S. production of the “one-and-done” shot.A manufacturing subcontractor in Baltimore mixed ingredients from the coronavirus vaccines of Johnson & Johnson and AstraZeneca, setting back U.S. production of the “one-and-done” shot.Vaccination and Immunization, Drugs (Pharmaceuticals), Factories and Manufacturing, Johnson & Johnson, Emergent BioSolutions Inc, Coronavirus (2019-nCoV), Food and Drug Administration, Regulation and Deregulation of IndustryRead More
